Ebinger, M.; Grauer, M. T.; Weiser, C.; Rickel, S.; Franc, D.; Uhr, M.: Results of routine CSF analysis of 1000 psychiatric patients. Pharmacopsychiatry 36 (5), p. 222 - 222 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Pharmacopsychiatry 36 (5), p. 223 - 223 (2003)

Erhardt, A.; Welt, T.; Rödel, A.; Habersetzer, U.; Stecker, G.; Ohl, F.; Keck, M. E.: Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry 36 (5), p. 223 - 223 (2003)

Erhardt, A.; Welt, T.; Schmidt, W.; Sillaber, I.; Keck, M. E.: Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry 36 (5), pp. 223 - 224 (2003)

Grauer, M. T.; Namendorf, C.; Ebinger, M.; Rippel, A.; Uhr, M.: Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls. Pharmacopsychiatry 36 (5), pp. 228 - 229 (2003)

Greetfeld, M.; Müller, M. B.: Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation. Pharmacopsychiatry 36 (5), p. 229 - 229 (2003)

Haberger, C.; Finke, K.; Bublak, P.; Schneider, W.: A new diagnostic tool for measuring attentional components in patients with depression. Pharmacopsychiatry 36 (5), pp. 229 - 230 (2003)

Held, K.; Mathias, S.; Schüssler, P.; Weikel, J. C.; Steiger, A.: GHRH impairs sleep in normal females. Pharmacopsychiatry 36 (5), p. 232 - 232 (2003)

Henniger, M. S. H.; Sillaber, I.: Choosing the right black mice - a matter of particular importance! Pharmacopsychiatry 36 (5), p. 232 - 232 (2003)

Herr, A. S.; Tsolakidou, A.; Yassouridis, A.; Holsboer, F.; Rein, T.: Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Pharmacopsychiatry 36 (5), p. 233 - 233 (2003)

Himmerich, H.; Kaufmann, C.; Schuld, A.; Pollmächer, T.: Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. Pharmacopsychiatry 36 (5), pp. 234 - 235 (2003)

Himmerich, H.; Koethe, D.; Schuld, A.; Pollmächer, T.: Body weight and the plasma levels of leptin and enclogenous immune modulators during treatment with carbamazepine or lithium. Pharmacopsychiatry 36 (5), p. 235 - 235 (2003)

Himmerich, H.; Kraus, T.; Pollmächer, T.: Epidemiology and mechanisms of weight gain induced by psychotropic drugs. Pharmacopsychiatry 36 (5), p. 235 - 235 (2003)

Himmerich, H.; Schuld, A.; Haack, M.; Kaufmann, C.; Pollmächer, T.: Early prediction of changes in weight during six weeks of treatment with antidepressants. Pharmacopsychiatry 36 (5), p. 235 - 235 (2003)

Hölter, S. M.; Kallnik, M.; van Gaalen, M. M.; Steckler, T.; Marsicano, G.; Lutz, B.: Mice deficient for the cannabinoid receptor type 1 show normal attention in five choice serial reaction time task. Behavioural Pharmacology 14 (Suppl. 1), p. S32 - S32 (2003)

Ising, M.; Adena, S. M.; Pfennig, A.; Binder, E. B.; Kern, N.; Huber, J.; Modell, S.; Holsboer, F.: Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes. Pharmacopsychiatry 36 (5), p. 237 - 237 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), p. 237 - 237 (2003)

Izzo, A. A.; Capasso, F.; Costagliola, A.; Bisogno, T.; Marsicano, G.; Ligresti, A.; Matias, I.; Capasso, R.; Pinto, L.; Borrelli, F. et al.; Cecio, A.; Lutz, B.; Mascolo, N.; Di Marzo, V.: An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 125 (3), pp. 765 - 774 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders. Pharmacopsychiatry 36 (5), p. 239 - 239 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), p. 239 - 239 (2003)